Literature DB >> 7813483

Aspartate-bond isomerization affects the major conformations of synthetic peptides.

G I Szendrei1, H Fabian, H H Mantsch, S Lovas, O Nyéki, I Schön, L Otvos.   

Abstract

The aspartic acid bond changes to an beta-aspartate bond frequently as a side-reaction during peptide synthesis and often as a post-translational modification of proteins. The formation of beta-asparate bonds is reported to play a major role not only in protein metabolism, activation and deactivation, but also in pathological processes such as deposition of the neuritic plaques of Alzheimer's disease. Recently, we reported how conformational changes following the aspartic-acid-bond isomerization may help the selective aggregation and retention of the amyloid beta peptide in affected brains (Fabian et al., 1994). In the current study we used circular dichroism, Fourier-transform infrared spectroscopy, and molecular modeling to characterize the general effect of the beta-aspartate-bond formation on the conformation of five sets of synthetic model peptides. Each of the non-modified, parent peptides has one of the major secondary structures as the dominant spectroscopically determined conformation: a type I beta turn, a type II beta turn, short segments of alpha or 3(10) helices, or extended beta strands. We found that both types of turn structures are stabilized by the aspartic acid-bond isomerization. The isomerization at a terminal position did not affect the helix propensity, but placing it in mid-chain broke both the helix and the beta-pleated sheet with the formation of reverse turns. The alteration of the geometry of the lowest energy reverse turn was also supported by molecular dynamics calculations. The tendency of the aspartic acid-bond isomerization to stabilize turns is very similar to the effect of incorporating sugars into synthetic peptides and suggests a common feature of these post-translational modifications in defining the secondary structure of protein fragments.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7813483     DOI: 10.1111/j.1432-1033.1994.t01-1-00917.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  Chemical modification of insulin in amyloid fibrils.

Authors:  Melanie R Nilsson; Christopher M Dobson
Journal:  Protein Sci       Date:  2003-11       Impact factor: 6.725

2.  The CLN025 decapeptide retains a β-hairpin conformation in urea and guanidinium chloride.

Authors:  Marcus P D Hatfield; Richard F Murphy; Sándor Lovas
Journal:  J Phys Chem B       Date:  2011-04-11       Impact factor: 2.991

Review 3.  APP/Aβ structural diversity and Alzheimer's disease pathogenesis.

Authors:  Alex E Roher; Tyler A Kokjohn; Steven G Clarke; Michael R Sierks; Chera L Maarouf; Geidy E Serrano; Marwan S Sabbagh; Thomas G Beach
Journal:  Neurochem Int       Date:  2017-08-12       Impact factor: 3.921

4.  Hexapeptide fragment of carcinoembryonic antigen which acts as an agonist of heterogeneous ribonucleoprotein M.

Authors:  Nicholas Y Palermo; Peter Thomas; Richard F Murphy; Sándor Lovas
Journal:  J Pept Sci       Date:  2012-03-06       Impact factor: 1.905

5.  A conserved deamidation site at Asn 2 in the catalytic subunit of mammalian cAMP-dependent protein kinase detected by capillary LC-MS and tandem mass spectrometry.

Authors:  P T Jedrzejewski; A Girod; A Tholey; N König; S Thullner; V Kinzel; D Bossemeyer
Journal:  Protein Sci       Date:  1998-02       Impact factor: 6.725

6.  Glutamate transporter homolog-based model predicts that anion-π interaction is the mechanism for the voltage-dependent response of prestin.

Authors:  Sándor Lovas; David Z Z He; Huizhan Liu; Jie Tang; Jason L Pecka; Marcus P D Hatfield; Kirk W Beisel
Journal:  J Biol Chem       Date:  2015-08-17       Impact factor: 5.157

7.  VCD spectroscopic properties of the beta-hairpin forming miniprotein CLN025 in various solvents.

Authors:  Marcus P D Hatfield; Richard F Murphy; Sándor Lovas
Journal:  Biopolymers       Date:  2010-05       Impact factor: 2.505

8.  The structure of bioactive analogs of the N-terminal region of gastrin-17.

Authors:  Jeffrey Copps; Richard F Murphy; Sándor Lovas
Journal:  Peptides       Date:  2009-09-18       Impact factor: 3.750

Review 9.  Truncated and modified amyloid-beta species.

Authors:  Markus P Kummer; Michael T Heneka
Journal:  Alzheimers Res Ther       Date:  2014-05-26       Impact factor: 6.982

10.  Chiral Interface of Amyloid Beta (Aβ): Relevance to Protein Aging, Aggregation and Neurodegeneration.

Authors:  Victor V Dyakin; Thomas M Wisniewski; Abel Lajtha
Journal:  Symmetry (Basel)       Date:  2020-04-07       Impact factor: 2.713

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.